Zuclopenthixol acetate prescribing in primary care by all Sub-ICB Locations
Why it matters: The BNF has a safety warning advising that zuclopenthixol acetate should only be used in hospitals as it is a relatively short-acting antipsychotic. Sometimes it may be confused with zuclopnethixol decanoate, a long-acting antipsychotic which is more commonly prescribed in primary care supporting long term maintenance.
Any prescribing on this measure could prompt investigation to ascertain if zuclopenthixol acetate was prescribed in error.
Please note that this is an experimental measure to support a new type of alert. We would be grateful for any feedback at [email protected] and you can read more about the measure on our blog.
Description: Number of items for zuclopenthixol acetate items as a proportion of all injectable zuclopenthixol items
Explore:
Tagged as: Mental Health, Safety (or browse all measures)
Sub-ICB Locations are ordered by mean percentile over the past six months. Each chart shows the results for the individual Sub-ICB Location, plus deciles across all Sub-ICB Locations in the NHS in England.
View measure for NHS England combined →
Fetching data...